open-burger-menu
Search Icon
Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research
📈 NEW Report: Abortions, Tax Funding UP at Planned Parenthood >>
Search Icon
Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

close-panel
Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research
526 results

Sort 526 results by:

Filter results further
Filter Applied. Clear All

Latest Posts

October 6, 2026 A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review October 6, 2026 Inside The Government Decision That Opened Up Abortion Pill Floodgates Inside The Government Decision That Opened Up Abortion Pill Floodgates October 6, 2026 Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone
Research Type
Publication Type
By State
See All
By Author
See All
Reset All Filters

Did You Know ?

Did You Know ?

In the fourth week, the embryonic heart starts beating. The neural tube, which becomes the brain and spinal cord, forms. At this point, a woman has likely only been aware of her pregnancy for one week.

Did You Know ?

In the seventh week after conception, networks of neurons produce brain waves that have been recorded as early as 6 ½ weeks after conception. The embryo spontaneously moves his arms, hands, and legs, and may even hiccup. The embryo’s heart now has all four chambers.

Did You Know ?

By the seventeenth and eighteenth week after gestation, the fetus shows a clear response to pain in multiple studies, and at least one brain pathway is mature enough to create a perception of pain. The fetus also practices breathing, crying, and breastfeeding in the womb. The fetal heart has beat over 20 million times and circulates about 55 quarts of blood per day.

Did You Know ?

In the eighth month of pregnancy the fetal brain is ready to learn! At 32 weeks after conception, neurons are creating 40,000 new connections, called synapses, every second! With repeated exposures, the fetus can learn flavors, nursery rhymes, songs, and even words that she will recognize after birth!

A magnifying glass rests on three wooden blocks that spell out FDA, symbolizing a review of the REMS modification.

A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review

This paper critically analyzes the FDA's 2021 REMS Review leading to the removal of the in-person dispensing requirement for mifepristone.

Zachary Sluzala, Ph.D. Ingrid Skop, M.D., FACOG
October 6, 2026
Ultrasound image showing the side profile of a human baby

Inside The Government Decision That Opened Up Abortion Pill Floodgates

The decision "fell well short" of the FDA's standards.

charlotte-lozier-institute Charlotte Lozier Institute
October 6, 2026
A sign for the FDA featuring the agency’s logo and circular seals in front of a brick government building, where clinical guidance for mifepristone REMS is often determined.

Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone

This paper critically analyzes the FDA's 2021 literature review that served as the basis for its controversial decision to remove…

Ingrid Skop, M.D., FACOG
October 6, 2026
A person in a white shirt dropping an abortion ballot into a white box against a yellow background.

Abortion on the Ballot in November

On November 3, 2026, voters in four states will consider ballot measures on abortion. This paper examines how these provisions,…

Mary E. Harned, J.D.
October 2, 2026
CLI logo

At 50, the Hyde Amendment’s lifesaving legacy needs defending

On Wednesday, the federal Hyde Amendment turns 50 years old. First passed on Sept. 30, 1976, the Hyde Amendment is…

Michael J. New, Ph.D.
September 30, 2026
CLI logo

Peer-Reviewed Research on Online Narratives About Abortion Drugs

CLI Associate Scholar Katherine Rafferty, Ph.D., discussed her research on online narratives about abortion drugs post-Dobbs in a webinar.

Katherine Rafferty, Ph.D., M.A.
September 25, 2026
A woman sits cross-legged on a bed, holding her stomach with one hand and touching her forehead with the other, appearing to be in discomfort or pain—an image that may reflect the emotional and physical toll following pregnancy loss.

A History of Pregnancy Loss is a Risk Factor for Severe Maternal Morbidity in a First Live Birth: A Retrospective Cohort Study

This new peer-reviewed study from CLI scholars examined the associations between prior pregnancy loss and the risk of severe maternal…

David C. Reardon, Ph.D. James Studnicki, Sc.D., MPH, MBA
September 25, 2026
A person with pink nail polish holds a glass of water in one hand and a white pill in the other, their head bowed down, partially obscured by their hair—a quiet moment that reflects many women’s experiences as shared through online narratives about medication abortion.

Examining women’s experiences with medication abortion: a critical inquiry of women’s online narratives post-Dobbs

This new peer-reviewed study from CLI scholars examined the experiences of women who had a medication abortion and chose to…

Katherine Rafferty, Ph.D., M.A. Tessa Cox
September 16, 2026

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image